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Abstract
Background: In type 2 diabetes, free fatty acids (FFA) accumulate in microvascular cells, but the
phenotypic consequences of FFA accumulation in the microvasculature are incompletely
understood. Here we investigated whether saturated FFA induce apoptosis in human microvascular
mesangial cells and analyzed the signaling pathways involved.
Methods: Saturated and unsaturated FFA-albumin complexes were added to cultured human
mesangial cells, after which the number of apoptotic cells were quantified and the signal
transduction pathways involved were delineated.
Results: The saturated FFA palmitate and stearate were apoptotic unlike equivalent
concentrations of the unsaturated FFA oleate and linoleate. Palmitate-induced apoptosis was
potentiated by etomoxir, an inhibitor of mitochondrial β-oxidation, but was prevented by an
activator of AMP-kinase, which increases fatty acid β-oxidation. Palmitate stimulated an intrinsic
pathway of pro-apoptotic signaling as evidenced by increased mitochondrial release of cytochrome-
c and activation of caspase 9. A caspase 9-selective inhibitor blocked caspase 3 activation but
incompletely blocked apoptosis in response to palmitate, suggesting an additional caspase 9-
independent pathway. Palmitate stimulated mitochondrial release of endonuclease G by a caspase
9-independent mechanism, thereby implicating endonuclease G in caspase 9-indpendent regulation
of apoptosis by saturated FFA. We also observed that the unsaturated FFA oleate and linoleate
prevented palmitate-induced mitochondrial release of both cytochrome-c and endonuclease G,
which resulted in complete protection from palmitate-induced apoptosis.
Conclusions: Taken together, these results demonstrate that palmitate stimulates apoptosis by
evoking an intrinsic pathway of proapoptotic signaling and identify mitochondrial release of
endonuclease G as a key step in proapoptotic signaling by saturated FFA and in the anti-apoptotic
actions of unsaturated FFA.
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Recent evidence suggests that intracellular accumulation
of saturated free fatty acids (FFA) in vascular cells contrib-
utes to lipid-mediated cellular damage (see [1-4] for
review). The cellular dysfunction associated with FFA
overload, known as lipotoxicity, contributes to cell injury
in settings of high FFA or triglycerides, such as obesity or
type 2 diabetes [4]. Diverse mechanisms have been pro-
posed to explain lipotoxicity including dysregulation of
cell signaling, induction of a proinflammatory and pro-
thrombotic state, or in some cases programmed cell death
[1,4]. Indeed, saturated FFA have previously been shown
to induce apoptotic cell death that is prevented in most
cell types by unsaturated FFA [5-14]. In the microvascula-
ture, the pro-apoptotic signaling pathways induced by sat-
urated FFA and the anti-apoptotic pathways regulated by
unsaturated FFA remain incompletely understood.
Several mechanisms have been implicated in apoptotic
cell death induced by saturated FFA. Some studies suggest
that increased β-oxidation of FFA does not contribute to
apoptotic cell death and suggest that unmetabolized FFA
might be involved [1,13]. However, other studies contra-
dict this observation and suggest a direct role for mito-
chondrial β-oxidation in the apoptotic response to
palmitate.[10]. The finding that long-chain saturated but
not unsaturated FFA cause apoptosis implicates a product
made specifically from the saturated species. For instance,
saturated but not unsaturated FFA are precursors for the
pro-apoptotic lipid ceramide. Although palmitate does
increase de novo ceramide synthesis in cultured cells, stud-
ies of the functional role of ceramide in palmitate-
induced apoptosis have yielded conflicting results that
might depend on the cell type in question [8,13,14].
Because saturated FFA are poor substrates for cardiolipin
biosynthesis, decrements in cardiolipin and increased
release of mitochondrial cytochrome-c have recently been
implicated in apoptosis in breast cancer cells and cardio-
myoctyes exposed to palmitate [12,13]. Another recent
study demonstrated mitochondrial release of cytochrome-
c in palmitate-treated pancreatic β-cells [14], which sug-
gests that an intrinsic mitochondrial pathway of pro-
apoptotic signaling might mediate the effects of saturated
FFA on cell death.
In the present study, we investigated the hypothesis that
the saturated FFA palmitate induces apoptosis in microv-
ascular mesangial cells and delineated the proapoptotic
signals involved. We chose to study mesangial cells
because lipids accumulate in mesangial cells in vivo in
experimental models of type 2 diabetes, obesity, or hyper-
lipidemia [15-20], but the functional consequences of
FFA accumulation are unclear. We report here that palmi-
tate induces an intrinsic proapoptotic signaling pathway
in mesangial cells that proceeds by a caspase 9-dependent
pathway and by a caspase 9 -independent mechanism
involving mitochondrial release of endonuclease G. In
addition, we demonstrate that unsaturated FFA block
both the caspase 9-dependent and -independent path-
ways of palmitate-stimulated apoptosis.
Methods
Reagents
Antibodies used in these studies were as follows: human-
specific active fragment of caspase 9 and human cyto-
chrome-c (Cell Signaling, Beverley MA,), human active
fragment caspase-8 and caspase-2 (BD Biosciences), endo-
nuclease G (Chemicon, Temecula, CA), and β-Actin
(Sigma, #A5316). Cell-permeable inhibitors of caspase 9
(Z-LEHD-FMK) and caspase-8 (Z-IETD-FMK) were from
R&D systems (Minneapolis, MN). Etomoxir and 5-ami-
noimidazole-4-carboxamide-1-β-D-ribonucleoside
(AICAR) were from Sigma and Toronto Research Chemi-
cals (Ontario, Canada), respectively.
Preparation of FFA-albumin complexes
Fatty acid-albumin solutions were prepared by the proto-
col of Spector [21]. Briefly, sodium salts of FFA (Nu-Chek
Prep, Elysian, MN) were added to PBS and gently warmed
to facilitate solubility without damaging the fatty acid
[21]. The warm, clear fatty acid salt solution was com-
plexed to 5% fatty acid-free BSA in PBS at a 6:1 fatty acid
to BSA molar ratio. The sterile filtered, complexed fatty
acid solution was added to the serum-containing cell cul-
ture medium to obtain the indicated final FFA concentra-
tion. The final FFA concentration in the medium was
confirmed with an enzymatic colorimetric assay (NEFA C,
Wako). We also confirmed that addition of the complex
to culture medium did not significantly alter the pH.
Apoptotic cell death in cultured human mesangial cells
Human mesangial cells (HMC), purchased from Cambrex
Bioscience Inc. (Walkersville, MD), were maintained in
Dulbecco's modified essential medium (Gibco-BRL) sup-
plemented with 17% fetal bovine serum (FBS), 100 U/ml
penicillin, 100 µg/ml streptomycin, 5 ng/ml selenite, and
5 µg/ml each of insulin and transferrin. Characterization
was performed by phase contrast microscopy and by
immunostaining for intermediate filaments and surface
antigens as described previously [22]. Briefly, cells were
positive for desmin, vimentin, and myosin, but did not
stain for factor VIII, keratin, or common leukocyte
antigen.
To measure endogenous levels of cleaved caspase-3, cells
were lysed in a buffer containing 20 mM Tris, pH 7.5, 150
mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 % Triton X-100,
2.5 mM Na pyrophosphate, 1 mM β-glycerophosphate, 1
mM Na3VO4, and 1 µg/ml luepeptin. After adjusting for
cell protein (DC Assay, BioRad, Hercules, CA), thePage 2 of 12
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ured by ELISA (Cell Signaling). For Western blotting of
cleaved caspase proteins, the cells were washed with ice
cold PBS and scraped in CHAPS extraction buffer(50 mM
Pipes/HCI, pH 6.5, 2 mM EDTA, 0.1% Chaps, 20 µg/ml
leupeptin, 10 µg/ml pepstatin A, 10 µg/ml aprotinin, 5
mM DTT, 2 mM Na pyrophosphate, 1 mM Na3VO4, and 1
mM NaF) and centrifuged at 2,000 × g for 10 min at 4°C.
Protein content in the supernatant was assayed with the
DC protein assay. An aliquot of the lysate (25 µg protein)
was boiled in SDS sample buffer, resolved on a 4–12%
SDS-PAGE gradient gel, and transferred to a 0.2 µm nitro-
cellulose membrane. After blocking in 5% non-fat dried
milk in TBS-T (20 mM Tris-Cl, pH 7.5, 150 mM NaCl,
0.05% Tween 20) for 1 h, the membrane was washed 3
times with TBS-T for 5 min each and incubated overnight
at 4°C with primary antibody in 3% BSA in TBS-T. After
incubating with suitable HRP-labeled secondary Ab
(1:2,000) and extensive washing, the proteins were
detected by chemiluminescence with an average exposure
ranging from 10–30 sec. As previously described [23], the
Western blots were analyzed by densitometry in NIH
Image by normalizing values for the relevant caspase frag-
ment to the highest value within each experiments (max-
imum level = 1).
To quantify the number of pyknotic nuclei, HMC on cov-
erslips were washed once with PBS and fixed for 20 min
with freshly-prepared 3.7% formaldehyde/20% sucrose in
PBS. After washing twice with PBS the HMC were stained
with 5 µg/ml Hoechst 33342 (Molecular Probes, Eugene
OR) and mounted in Slow Fade Light (Molecular Probes).
Using a Nikon Diaphot microscope, the number of
pyknotic nuclei were counted and expressed as a percent-
age of the total number of nuclei counted (n = >300 nuclei
per condition).
DNA fragmentation was assessed by measuring release of
nucleosomal fragments into the cytosol (Cell Death
Detection ELISA Plus, Roche). Briefly, HMC in 24-well
plates were centrifuged in situ for 10 min at 200 × g and
the supernatant gently removed. The monolayer was incu-
bated in lysis buffer for 30 min at room temperature and
centrifuged again at 200 × g. The supernatant (i.e.,
cytosolic fraction) was assayed immediately for nucleo-
somal fragments.
Enzymatic assay of caspase 9 in HMC
HMC treated with FFA were lysed (20 mM Tris, pH 7.5,
150 mM NaCl, 1.0% Triton X-100) and frozen at -40°C.
Equivalent amounts of total HMC protein were added to
buffer containing the LEHD caspase 9 peptide substrate
linked to a cleavable luciferase substrate, aminoluciferin
(Promega). The amount of light produced in a coupled
reaction with luciferase was measured once every hour for
3 hours in a Berthold Luminometer. Experiments with
increasing amounts of cell protein confirmed that the
assay was in the linear range under the conditions
described.
Measurements of cytochrome -c and endonuclease G 
redistribution
To analyze cytochrome-c redistribution in HMC treated
with FFA, cells were fractionated into cytosol and mem-
brane fractions using 0.05% digitonin in an isotonic
sucrose buffer exactly as described by Dong and coworkers
[24]. Because cytochrome-c release occurs mostly from
mitochondria, Western blot analysis of cytosol and mem-
brane fractions is expected to reflect cytochrome-c translo-
cation from mitochondria to the cytoplasm. In separate
experiments, the same protocol was used to assess release
into the cytoplasm of endonuclease G.
Results
Saturated but not unsaturated FFA cause apoptosis in 
cultured HMC
Intracellular accumulation of long-chain saturated FFA
(i.e., palmitate C16:0) has been shown to induce apopto-
sis in several cell types including cardiac myocytes and
pancreatic β-cells [5,6,8,11,13]. To determine whether
FFAs induce apoptosis in HMC, cells were incubated in
medium supplemented with palmitate, stearate, oleate, or
linoleate. The saturated FFA palmitate and stearate
increased apoptosis in HMC as evidenced by cleavage of
caspase-3 and DNA fragmentation (Fig. 1A,B). In contrast,
the unsaturated FFA oleate and linoleate did not increase
caspase-3 cleavage or DNA fragmentation compared to
cells incubated with albumin alone (Control, Fig. 1A,B).
The number of pyknotic nuclei, another prototypical fea-
ture of apoptotic cells, were significantly higher in palmi-
tate-treated cells whereas the number of pyknotic nuclei
in cell incubated with oleate were similar to control (Fig.
2A). To determine whether mitochondrial β-oxidation
was necessary for palmitate-induced apoptosis, the
number of pyknotic nuclei were measured in cells treated
with etomoxir, an inhibitor of carnitine palmitoyltrans-
ferase I. Etomoxir significantly amplified palmitate-
induced formation of pyknotic nuclei at 48 h (Fig. 2B).
The number of pyknotic nuclei was unaffected by eto-
moxir alone compared to control. In contrast, stimulating
fatty acid oxidation with AICAR, an activator of AMP-
kinase, abolished the increase in pyknotic nuclei with
palmitate (Fig. 2B). The doses of etomoxir and AICAR
used here have been previously demonstrated to inhibit
and stimulate, respectively, fatty acid β-oxidation [13].
Thus, using three different criteria for identifying apop-
totic cell death, these data demonstrate that the saturated
but not unsaturated FFA induces apoptosis in HMC, sim-
ilar to the proapoptotic effects of saturated FFA in other
cell types [5,6,8,11,13]. In addition, enhanced β-oxida-Page 3 of 12
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increased disposal of palmitate via oxidation apparently
protects mesangial cells.
Palmitate activates an intrinsic proapoptotic signaling 
pathway in HMC
We next investigated the signaling pathways by which
palmitate induces apoptosis in HMC. To begin answering
this question, we examined activation of initiator caspases
associated with different pathways of apoptotic signaling.
Cleavage of procaspase zymogens is required to form
active heterotetrameric caspase complexes, so we analyzed
the time course of caspase cleavage by Western blotting in
3 independent experiments. The p35 cleaved fragment of
caspase 9 was elevated in cells treated with palmitate (Fig.
3A,B). After 48 h of palmitate, the amount of cleaved cas-
pase 9 was similar to that in cells treated for 8 h with the
robust apoptotic stimulus staurosporine (Fig. 3A, Pos
lane). In contrast, palmitate did not increase cleavage of
caspase-8 (Fig. 3A), but treatment with a strong caspase-8
Saturated but not unsaturated FFA induce apoptosis in cul-tured HMCFigure 1
Saturated but not unsaturated FFA induce apoptosis in cul-
tured HMC. HMC were plated for 24 h in media containing 
17% FBS, then incubated starting at time 0 with the indicated 
FFA at 0.2 mM complexed to albumin or with albumin alone 
(Control), all in media containing 5% FBS. After 24 and 48 h, 
the level of (A) the cleaved fragment of caspase-3 and (B) 
cytoplasmic nucleosomal fragments were determined by 
ELISA and expressed relative to the 24 h control value. Data 
are mean ± SEM for n = 3 independent experiments in tripli-
cate. **, P < 0.01 by ANOVA versus control, oleate, or 
linoleate alone.
Palmitate-induced formation of pyknotic nuclei and the role of i ochondrial β- xidationFigure 2
Palmitate-induced formation of pyknotic nuclei and the role 
of mitochondrial β-oxidation. (A) HMC were treated with 
palmitate (Palm) or oleate as described in Fig. 1, and the 
number of pyknotic nuclei were counted after 24 and 48 h in 
the presence of FFA. (B) HMC incubated with 0.2 mM palmi-
tate in the presence and absence of 0.2 mM etomoxir (Etom) 
or 0.5 mM AICAR. Cells were also incubated with the same 
doses of etomoxir or AICAR alone. Data are mean ± SEM 
for n = 3 independent experiments in duplicate. **, P < 0.01 
versus control (Con) or oleate alone (A) by Chi-square test.Page 4 of 12
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caspase-8 and that the Western blot correctly measured
caspase-8 cleavage (Fig. 3A, Pos lane). Caspase-2 has
recently been implicated as an initiator caspase in signals
involving stress in the endoplasmic reticulum or nucleus
[25]. However, palmitate did not induce caspase-2 cleav-
age in HMC whereas the known caspase-2 stimulus camp-
tothecin activated robust cleavage of the p15 fragment
(Fig. 3A). Reprobing of all blots for β-actin confirmed
equal protein loading (Fig. 3A). Collectively, these results
suggest that palmitate activates caspase 9, an important
initiator caspase in the intrinsic pathway of proapoptotic
signal transduction.
To confirm that palmitate activated caspase 9, we used a
luminometric caspase 9 substrate to directly measure cas-
pase 9 enzyme activity in cytosolic extracts of HMC.
Palmitate at 0.4 mM increased caspase 9 activity 2.2- and
4.8-fold at 24 and 48 h, respectively (Fig. 4). A lower dose
of palmitate (0.2 mM) that also stimulated apoptosis (Fig.
2) increased caspase 9 activity. Importantly, oleate (0.4
mM) did not stimulate caspase 9 activity above control
levels at any time point tested (Fig. 4). These results con-
firm that the saturated FFA palmitate increases caspase 9
enzyme activity.
Because activation of caspase 9 by palmitate points to an
intrinsic pathway of proapoptotic signaling, we asked
whether palmitate could stimulate release of cytochrome-
c from mitochondria. Redistribution of cytochrome-c to
the cytoplasm is an important step in apoptosome forma-
tion and greatly enhances the enzymatic activity of cas-
pase 9 [25,26]. Western blotting of cytoplasmic and
membrane-enriched fractions that contain mitochondria
was used to assess cytochrome-c distribution. In control
cells (5% FBS plus albumin alone), cytochome-c resided
Palmitate stimulates cleavage of caspase 9 in HMCFigure 3
Palmitate stimulates cleavage of caspase 9 in HMC. (A) HMC 
treated with palmitate were analyzed for caspase cleavage by 
Western blotting of total HMC lysates with antibodies that 
recognize the cleavage products of human caspase 9 (p35), 
caspase-8 (p40 and p23), and caspase-2 (p15). For a positive 
control in each experiment, cells were treated for 8 h with 
an agent known to be a strong stimulus for the caspase in 
question: caspase 9, staurosporine 1 µM; caspase 8, etopo-
side 25 µM; and caspase 2, camptothecin 6 µM. The blots 
were reprobed with β-actin to ensure equal protein loading. 
(B) Densitometric analysis (mean ± SEM) of the p35 caspase 
9 fragment from 3 independent experiments. **, P < 0.01 by 
ANOVA versus control.
Palmitate but not oleate increases caspase 9 enzyme activityFigure 4
Palmitate but not oleate increases caspase 9 enzyme activity. 
HMC were treated with palmitate (0.2 and 0.4 mM) or oleate 
(0.4 mM) for 24 and 48 h. Caspase 9 activity was then meas-
ured in HMC extracts adjusted for total protein using a lumi-
nometric assay with an LEHD peptide substrate as described 
in Materials and Methods. Data are mean ± SEM for n = 3 
experiments in duplicate. **, P < 0.01, *, P < 0.05 versus con-
trol or oleate alone by ANOVA.Page 5 of 12
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treated with palmitate, a portion of total cytochrome-c
was redistributed to the cytoplasmic fraction. Consistent
with the inability of oleate to activate caspase 9, oleate did
not appreciably redistribute cytochrome-c to the cytosol
(Fig. 5). These results provide additional evidence that
palmitate activates an intrinsic pathway of proapoptotic
signaling in HMC.
Inhibition of caspase 9 attenuates palmitate-induced 
apoptosis in HMC
We next tested the functional role of caspase 9 activation
in the palmitate-induced signal transduction cascade. Co-
incubation with a cell-permeable selective inhibitor of
caspase 9 blocked activation of caspase 9 enzyme activity
by palmitate (Fig. 6A). The caspase 9 inhibitor alone had
a minor effect (<0.2-fold inhibition) on basal caspase 9
activity, and a caspase-8 inhibitor did not block caspase 9
activity stimulated by palmitate (Fig. 6A). Under theses
conditions, inhibition of caspase 9 abolished caspase-3
cleavage in cells treated with palmitate for 24 and 48 h
(Fig. 6B). Formation of pyknotic nuclei by 0.2 mM
palmitate was blocked in cells treated with the caspase 9
inhibitor at both 24 and 48 h. However, the number of
pyknotic nuclei was only partially reduced in cells treated
with 0.4 mM palmitate for 48 h (Fig 6C), even though
under these conditions caspase 9 enzyme activity was
completely inhibited (Fig. 6A). Similarly, DNA fragmen-
tation by palmitate was incompletely blocked by the
caspase 9 inhibitor at 48 h (Fig. 6D). These results show
that inhibition of palmitate-stimulated caspase 9 blocks
some but not all apoptotic death in HMC. Because the cas-
pase 9 inhibitor completely blocked caspase-3 cleavage,
these results also suggest that proapoptotic signaling by
palmitate proceeds by both caspase 9/3-dependent and
independent mechanisms.
Mitochondrial release of endonuclease G in palmitate-
treated HMC
To elucidate the caspase 9/3-independent mechanisms of
proapoptotic signaling by palmitate, we investigated the
possibility that palmitate stimulates the release of other
mitochondrial proapoptotic proteins that can contribute
to nuclear changes independent of casapse-3. Endonucle-
ase G is one such effector of apoptosis, a mitochondrial
DNase released by a Bcl-2-dependent but caspase-inde-
pendent mechanism [27]. To examine the extent to which
palmitate can induce endonuclease G release, we treated
HMC with palmitate and measured the presence of endo-
nuclease G in the cytoplasm of fractionated cells. Palmi-
tate increased the amount of endonuclease G released into
the cytoplasm (Fig. 7A and 7B). The release of endonucle-
ase G in palmitate-treated cells was not altered by caspase
9 inhibition (Fig. 7A and 7B). These results are consistent
with the incomplete inhibition of DNA fragmentation
observed when caspase 9 activation by palmitate was
blocked in HMC (Fig. 6D). Collectively, these results sug-
gest that palmitate-induced apoptosis proceeds by caspase
9-dependent mechanisms and by a caspase 9 -independ-
ent mechanism involving endonuclease G.
Caspase 9-dependent and -independent pathways of 
palmitate-induced apoptosis are abolished by unsaturated 
FFA
Unsaturated FFA have been reported to block apoptosis
by saturated FFA [8,11,13], so we next asked whether
unsaturated FFA block palmitate-induced apoptosis in
HMC and whether they act by inhibiting the caspase 9-
dependent or -independent pathway. The unsaturated
FFA oleate and linoleate blocked the increase in caspase-3
cleavage and DNA fragmentation in cells treated with
Palmitate induces translocation of cytochrome-c in cultured HMCFigure 5
Palmitate induces translocation of cytochrome-c in cultured 
HMC. (A) Cells treated with control (Con, i.e., albumin 
alone), palmitate (Palm, 0.4 mM), oleate (Ole, 0.4 mM), or 
staurosporine (St, 1 µM) for the times indicated. HMC were 
then rapidly separated into soluble cytosolic and insoluble 
membrane fractions. The amount of cytochrome-c (Cyto-C) 
was determined by Western blotting. Equivalent amounts of 
total protein were present across all lanes of the cytoplasmic 
and membrane fractions, but the membrane fractions con-
tained approximately 3 times more protein than the corre-
sponding lane in the cytoplasmic fraction. (B) Densitometric 
analysis of cytoplasmic p14 kDa cytochrome-c from 3 inde-
pendent experiments. Data are mean ± SEM. **, P < 0.01 by 
ANOVA versus control and oleate alone.Page 6 of 12
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Effect of caspase 9 inhibition on apoptosis of HMC induced by palmitate. (A) Cells were treated with control (Con) or palmi-
tate (Palm) in the presence and absence of the cell permeable caspase 9 inhibitor (C9I, Z-LEHD-FMK) or the caspase 8 inhibi-
tor (C8I, Z-IETD-FMK), both at 40 µM. Addition of the caspase inhibitors was concurrent with addition of the FFA. After 24 
and 48 h, caspase 9 enzyme activity was measured and expressed as fold-change over control. (B) Palmitate and Z-LEHD-FMK 
were added to HMC as above, and cleavage of caspase-3 was measured by ELISA as described in Experimental Procedures. (C) 
The number of pyknotic nuclei was assessed in cells treated with palmitate with and without Z-LEHD-FMK. (D) DNA fragmen-
tation, assessed by ELISA as the number of nucleosomal fragments in the cytosol, was measured in cells treated with palmitate 
and by Z-LEHD-FMK. For A-D, data are mean ± SEM for 3 independent experiments. **, P < 0.01, *, P < 0.05 versus control by 
ANOVA in (A, B and D) or Chi-square test in (C).Page 7 of 12
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also effectively blocked in cells co-incubated with oleate
or linoleate (Fig. 8A,B). Oleate also prevented the increase
in caspase 9 activity in cells treated with palmitate (Fig. 9).
The specificity of this assay for caspase 9 was confirmed by
showing that the cell-permeable caspase 9 inhibitor pre-
vented palmitate-stimulated enzyme activity whereas a
caspase 8-selective inhibitor had no effect (Fig. 9). Thus,
similar to other cell types, unsaturated FFA inhibit the
apoptotic response to saturated FFA in HMC. Moreover,
oleate and linoleate completely prevent palmitate-
induced apoptosis, which contrasts with the partial block-
ade observed with inhibition of caspase 9 (Fig. 6).
Because the unsaturated FFA more effectively blocked
palmitate-induced apoptosis, we investigated whether
this was because they blocked the caspase-independent
release of endonuclease G in cells treated with palmitate.
As expected, palmitate increased mitochondrial release of
cytochrome-c and endonuclease G in HMC (Fig. 10A,B).
Oleate alone had no effect on release of cytochrome-c or
endonuclease G. Co-incubation of oleate with palmitate
prevented the release of cytochrome-c and endonuclease
G induced by palmitate (Fig. 10A,B). These results are
consistent with the notion that oleate blocks both the cas-
pase 9-dependent and -independent mechanisms of proa-
poptotic signaling by palmitate. In particular, the ability
Palmitate stimulates translocation of the proapoptotic endo-nuclease G protein by a casp se 9-independent mechanismFigure 7
Palmitate stimulates translocation of the proapoptotic endo-
nuclease G protein by a caspase 9-independent mechanism. 
(A) HMC were incubated with palmitate (Palm) and palmitate 
plus the Z-LEHD-FMK caspase 9 inhibitor (C9I, 40 µM) for 
the times indicated. The cells were fractionated and the level 
of p33 endonuclease G protein was measured by Western 
blotting in the cytoplasmic fraction. Equivalent amounts of 
protein were added to each lane, as confirmed by reprobing 
with β-actin. (B) Densitometry of cytoplasmic p33 kDa endo-
nuclease G protein from 3 independent experiments. **, P < 
0.01, *, P < 0.05 by ANOVA versus 0 time.
Unsaturated FFA block apoptosis induced by saturated FFAFigure 8
Unsaturated FFA block apoptosis induced by saturated FFA. 
HMC were incubated for 24 or 48 h with 0.2 mM palmitate 
(Palm) or stearate (Ste) alone or in co-incubations with 0.2 
mM of the unsaturated FFA oleate (Ole) or linoleate (Lin). 
Control cells were incubated with albumin alone. After 24 
and 48 h, the level of (A) the cleaved fragment of caspase-3 
and (B) cytoplasmic nucleosomal fragments were determined 
by ELISA and expressed relative to the 24 h control value. 
Data are mean ± SEM for n = 3 independent experiments in 
triplicate. **, P < 0.01 by ANOVA versus control.Page 8 of 12
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treated cells is one explanation for the superior antiapop-
totic effect of oleate compared to caspase 9 antagonism.
Discussion
Our results show that the saturated FFA palmitate induces
an intrinsic pathway of proapoptotic signaling in HMC, a
vascular target cell of lipid-mediated injury in the kidney.
In contrast, the monounsaturated FFA oleate did not
induce proapoptotic signaling and instead protected
HMC from palmitate-induced apoptosis. Evidence that
palmitate induced an intrinsic pathway of proapoptotic
signaling is that it increased cytochrome-c release, caspase
9 cleavage, and caspase 9 enzyme activity. We also showed
that the palmitate-stimulated intrinsic pathway proceeded
by a caspase 9-dependent mechanism and by a caspase 9
-independent mechanism involving endonuclease G.
Both the caspase 9-dependent and -independent path-
ways were effectively blocked by oleate.
In this study we report that palmitate causes apoptosis in
HMC, a microvascular cell that accumulates lipids in vivo
in settings of high FFA such as obesity and type 2 diabetes
[15-20]. We chose palmitate because it is the most abun-
dant saturated FFA complexed to human serum albumin
[28]. We used complexes where the molar ratio of FFA to
albumin was 6:1. Although the normal physiologic ratio
of FFA to albumin is approximately 2:1, serum FFA levels
are greatly elevated in patients with obesity, type 2
diabetes, and proteinuric renal diseases, yielding ratios of
6:1 or higher [29,30]. In addition, normal circulating FFA
levels are approximately 0.5 mM [3], so the concentra-
tions of individual FFA species (i.e., 0.2 – 0.4 mM) used in
this study seem reasonable. Therefore, our experiments
were designed to evaluate mechanisms of FFA-induced
apoptosis relevant to type 2 diabetes.
Previous studies have demonstrated that saturated but not
monounsaturated FFA cause apoptosis in other non-renal
cell types [5,6,8,11,13], but the ability of FFA to induce
apoptosis appears to vary with the specific cell type in
question [1]. In addition, the signal transduction
pathways by which saturated FFA induce apoptosis are
incompletely defined. Similar to a previous report in
breast cancer cells [13], palmitate-induced apoptosis in
HMC was enhanced by inhibition of fat oxidation and
reversed by increasing fat oxidation. Although we did not
directly measure the effects of these compounds on fatty
acid oxidation, these results suggest that palmitate must
be metabolized to promote apoptosis and that mitochon-
drial β-oxidation of the saturated FFA does not participate
in the proapoptotic response to palmitate. Several obser-
vations from our study suggest that palmitate induces an
intrinsic pathway of apoptotic signaling in HMC. First,
palmitate stimulated accumulation of cytochrome-c in
the cytosol, which is an important step in the intrinsic
pathway to promote apoptosome formation and
activation of caspase 9. Palmitate-induced release of cyto-
chrome-c has been previously reported in β-cells and
breast cancer cells [13,14]. Palmitate has also been shown
to stimulate release of uncharacterized proapoptotic pro-
teins when added directly to isolated mitochondria [31].
Second, palmitate stimulated caspase 9 cleavage and activ-
ity in HMC. To our knowledge activation of caspase 9 by
palmitate has not been previously shown. Caspase 9 is an
initiator caspase in many but not all intrinsic pathways of
proapoptotic signaling [25,26]. In a stimulus- and cell
type-specific manner, caspase 2 can function upstream of
caspase 9 [32-35], but in our experiments palmitate did
not stimulate cleavage of caspase 2, an indicator of
caspase 2 activation. Also, we did not observe cleavage of
caspase 8, an initiator caspase in the death receptor path-
way, in response to palmitate. Thus an important result of
our study is that the intrinsic pathway in palmitate-
induced apoptosis appears to involve caspase 9.
A functional role for caspase 9 in palmitate-induced apop-
tosis was suggested by experiments in which a cell-perme-
able caspase 9 inhibitor, Z-LEHD-FMK, blocked apoptosis
Oleate inhibits caspase 9 activation by palmitateFigur  9
Oleate inhibits caspase 9 activation by palmitate. HMC were 
treated with palmitate (0.2 and 0.4 mM) or palmitate plus 
oleate (0.2 mM) for 24 and 48 h. Caspase 9 activity was then 
measured in HMC extracts adjusted for total protein. In 
some experiments the cells were treated with palmitate plus 
selective inhibitors of caspase 9 (C9I) or caspase 8 (C8I) at 
40 µM. Data are mean ± SEM for n = 3 experiments in dupli-
cate. **, P < 0.01, *, P < 0.05 versus control or palmitate plus 
oleate by ANOVA.Page 9 of 12
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Cardiovascular Diabetology 2005, 4:2 http://www.cardiab.com/content/4/1/2Oleate prevents mitochondrial release of cytochrome-c and endonuclease G in cell treated with palmitateFigur  10
Oleate prevents mitochondrial release of cytochrome-c and endonuclease G in cell treated with palmitate. (A) HMC were 
incubated with 0.2 mM palmitate (Palm), 0.2 mM oleate (Ole), or palmitate plus oleate for the times indicated. The cells were 
fractionated and the levels of cytoplasmic p14 kDa cytochrome-c (Cyto-c) or p33 kDa endonuclease G (Endo-G) protein were 
measured by Western blotting. Equivalent amounts of protein were added to each lane, as confirmed by reprobing with β-
actin. (B) Densitometry of cytoplasmic p14 kDa cytochrome-c and p33 kDa endonuclease G protein from 3 independent 
experiments. **, P < 0.01, *, P < 0.05 by ANOVA versus 0 time.Page 10 of 12
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inhibited the activation of caspase 9 at 24 and 48 h of 0.4
mM palmitate. Under these conditions, Z-LEHD-FMK
reversed caspase-3 cleavage induced by palmitate, suggest-
ing that caspase 9 is required for activation of caspase-3 by
palmitate. While Z-LEHD-FMK effectively inhibited the
nuclear changes characteristic of apoptosis at 24 h, the
caspase 9 inhibitor did not completely reverse pyknotic
nuclei or DNA fragmentation at 48 h. For example, partial
inhibition of DNA fragmentation was observed in HMC
treated with 0.2 or 0.4 mM palmitate for 48 h, even
though the palmitate-induced increment in caspase 9 was
blocked. A possible explanation of these results is that
when HMC are exposed to palmitate for 48 h, the satu-
rated FFA recruits additional caspase 9-independent
mechanisms of apoptotic or non-apoptotic cell death that
are not induced at 24 h. A possible caspase 9-independent
mechanism for palmitate-induced apoptosis would be the
mitochondrial release of endonuclease G, which we dem-
onstrated in HMC. Endonuclease G is a DNase normally
located in the intermembrane space of mitochondria.
Some apoptotic stimuli cause caspase-independent
release of endonuclease G after which it translocates to the
nucleus and cleaves DNA [27]. Release of endonuclease G
in palmitate-treated HMC was not blocked by Z-LEHD-
FMK, which could explain the partial inhibition of DNA
fragmentation by Z-LEHD-FMK under conditions where
caspase 9 activation by palmitate was completely blocked.
It is also possible that a small amount of caspase 3 activity
remains even in the presence of the caspase 9 inhibitor,
and it is possible that this low level of caspase-3 activity
also contributes to endonuclease G release.
In striking contrast to the partial inhibition of palmitate-
induced apoptosis by the caspase 9 antagonist, we found
that the unsaturated FFA oleate and linoleate completely
prevented caspase 3 cleavage and DNA fragmentation in
cells treated with either palmitate or stearate. Oleate
prevented mitochondrial release of cytochrome-c and the
increase in caspase 9 in cells treated with palmitate. In
addition, oleate blocked mitochondrial release of endo-
nuclease G in palmitate-treated cells. Taken together,
these results support the notion that oleate completely
prevents palmitate-induced apoptosis because, unlike
inhibition of caspase 9 alone, oleate blocks both the cas-
pase 9-dependent and -independent pathways.
Conclusions
These results show that palmitate stimulates apoptosis by
evoking an intrinsic pathway of proapoptotic signaling. In
addition, we have identified mitochondrial release of
endonuclease G as a key step in proapoptotic signaling by
saturated FFA and in the anti-apoptotic actions of unsatu-
rated FFA. We believe that these results might be relevant
to the pathogenesis of microvascular injury in type 2 dia-
betes because FFA accumulate in microvascular cells,
including mesangial cells, in vivo in experimental models
of type 2 diabetes, obesity, or hyperlipidemia [15-20].
Thus lipid-driven apoptosis might contribute to the
microvascular remodeling that leads to numerous compli-
cations in type 2 diabetes.
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